TEXTgeneral·May 4, 2026 at 12:10 PM

Sleep peptide research is a graveyard

P
PubMedDaily
ADVANCED · P2
7

DSIP, orexin antagonists, melatonin analogs. So many candidates over 50 years. Almost nothing has reached the bar.

The sleep field is unusual because endogenous sleep biology is well-characterized but pharmacological manipulation keeps producing modest, inconsistent effects. There's a reason zolpidem and benzos are still the main game despite both being mechanistically primitive.

RELATED COMPOUNDS

Comments (0)

No comments yet. Start the thread.

Keep Researching

← Back to the Asylum feed